These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15622321)

  • 21. Lipodystrophy syndrome by HAART in HIV-infected patients: manifestation, mechanisms and management.
    Hirsch HH; Battegay M
    Infection; 2002 Oct; 30(5):293-8. PubMed ID: 12382089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult.
    Lee SM; Buchler T; Bomanji J; Ramsay A; Edwards SG
    AIDS; 2008 Jan; 22(1):159-60. PubMed ID: 18090408
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Control and treatment of HIV-associated lipodystrophy syndrome and related metabolic complications].
    Hansen BR; Haugaard SB; Nielsen JO; Madsbad S; Iversen J; Andersen O
    Ugeskr Laeger; 2003 Oct; 165(44):4218-20. PubMed ID: 14621554
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune reconstitution inflammatory syndrome due to Mycobacterium avium complex successfully followed up using 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a patient with human immunodeficiency virus infection: A case report.
    Namkoong H; Fujiwara H; Ishii M; Yagi K; Haraguchi M; Matsusaka M; Suzuki S; Asakura T; Asami T; Saito F; Fukunaga K; Tasaka S; Betsuyaku T; Hasegawa N
    BMC Med Imaging; 2015 Jul; 15():24. PubMed ID: 26187282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-associated lipodystrophy syndrome.
    Milinković A
    Coll Antropol; 2006 Dec; 30 Suppl 2():59-62. PubMed ID: 17508476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy.
    Nelson MD; Szczepaniak LS; LaBounty TM; Szczepaniak E; Li D; Tighiouart M; Li Q; Dharmakumar R; Sannes G; Fan Z; Yumul R; Hardy WD; Hernandez Conte A
    JACC Cardiovasc Imaging; 2014 Nov; 7(11):1175-7. PubMed ID: 25459601
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
    Kong HH; Myers SA
    Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. F-18 FDG PET visualization of urinary leak after nephrostomy tube removal.
    Iagaru A; Gamie S; Segall G
    Clin Nucl Med; 2007 Feb; 32(2):168-9. PubMed ID: 17242582
    [No Abstract]   [Full Text] [Related]  

  • 30. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome.
    Torriani M; Hadigan C; Jensen ME; Grinspoon S
    J Appl Physiol (1985); 2003 Sep; 95(3):1005-10. PubMed ID: 12766180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and treatment of sarcoidosis in an HIV-2-infected patient.
    Nicolini LA; Taramasso L; Ferrarazzo G; Fiz F; Sambuceti G; Viscoli C; Di Biagio A
    AIDS Res Hum Retroviruses; 2015 Sep; 31(9):868-9. PubMed ID: 25870097
    [No Abstract]   [Full Text] [Related]  

  • 32. What should we know about metabolic syndrome and lipodystrophy in AIDS?
    Signorini DJ; Monteiro MC; Andrade Mde F; Signorini DH; Eyer-Silva Wde A
    Rev Assoc Med Bras (1992); 2012; 58(1):70-5. PubMed ID: 22392319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy.
    Andersen O; Haugaard SB; Hansen BR; Orskov H; Andersen UB; Madsbad S; Iversen J; Flyvbjerg A
    Scand J Infect Dis; 2004; 36(11-12):832-9. PubMed ID: 15764170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.
    Ioannou GN; Bryson CL; Weiss NS; Boyko EJ
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):577-84. PubMed ID: 25769096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Webb RL; Landau E; Klein D; DiPoce J; Volkin D; Belman J; Voutsinas N; Brenner A
    Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
    Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
    J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
    Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
    Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity.
    ter Hofstede HJ; Burger DM; Koopmans PP
    Neth J Med; 2003 Dec; 61(12):393-403. PubMed ID: 15025414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.